Effect of Blue Light Filtration on Visual Performance
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate photostress recovery with blue light filter clip-on glasses among pseudophakes [ie, subjects in which the natural lens of the eye has been replaced with an artificial lens (intraocular lens) during cataract surgery]. This study will enroll subjects previously implanted with no blue light filter intraocular lenses (IOLs) for at least 3 months.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Clear, then Blue Light Filter Clear clip-on glasses first, followed by blue light filter clip-on glasses, as worn over habitual correction |
Device: Clear clip-on glasses
Clip-on glasses with no light filtering properties
Device: Blue light filter clip-on glasses
Clip-on glasses with blue light filtering properties equivalent to AcrySof IOLs
|
Other: Blue Light Filter, then Clear Blue light filter clip-on glasses first, followed by clear clip-on glasses, as worn over habitual correction |
Device: Clear clip-on glasses
Clip-on glasses with no light filtering properties
Device: Blue light filter clip-on glasses
Clip-on glasses with blue light filtering properties equivalent to AcrySof IOLs
|
Outcome Measures
Primary Outcome Measures
- Photostress Recovery Time [Day 1]
Photostress Recovery Time is the time necessary to recover function (e.g., contrast discrimination) following exposure to a bright glare source. The subject fixated on an image (black and white grating) and underwent photostress (glare) for 5 seconds. Only 1 eye (study eye) was assessed.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Cataract surgery in both eyes with no blue light filtering intraocular lenses for at least 3 months;
-
Good ocular health;
-
20/40 or better vision with best correction in both eyes;
-
Willing to provide voluntary consent and sign informed consent form;
-
Able to competently perform testing;
-
Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
-
Ocular pathology, degeneration, or media opacity (cloudiness) that could impact study measurements;
-
Other protocol-defined exclusion criteria may apply.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Alcon Research
Investigators
- Study Director: Stefani Smith, MS, Alcon Research
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- A01311
Study Results
Participant Flow
Recruitment Details | Participants were recruited from 6 study sites located in the US. |
---|---|
Pre-assignment Detail | Of the 158 enrolled, 2 participants were exited as screen failures prior to randomization. This reporting group includes all randomized and treated participants (154). Note: 2 participants were randomized but not treated. |
Arm/Group Title | Clear, Then Blue Light Filter | Blue Light Filter, Then Clear |
---|---|---|
Arm/Group Description | Clear clip-on glasses first, followed by blue light filter clip-on glasses, as worn over habitual correction | Blue light filter clip-on glasses first, followed by clear clip-on glasses, as worn over habitual correction |
Period Title: Overall Study | ||
STARTED | 77 | 77 |
COMPLETED | 77 | 77 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Overall |
---|---|
Arm/Group Description | Blue light filter clip-on glasses and clear clip-on glasses worn over habitual correction in a crossover assignment. |
Overall Participants | 156 |
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
69.9
(8.04)
|
Sex: Female, Male (Count of Participants) | |
Female |
91
58.3%
|
Male |
65
41.7%
|
Outcome Measures
Title | Photostress Recovery Time |
---|---|
Description | Photostress Recovery Time is the time necessary to recover function (e.g., contrast discrimination) following exposure to a bright glare source. The subject fixated on an image (black and white grating) and underwent photostress (glare) for 5 seconds. Only 1 eye (study eye) was assessed. |
Time Frame | Day 1 |
Outcome Measure Data
Analysis Population Description |
---|
This analysis population includes all participants with observation minus any major protocol deviations. |
Arm/Group Title | Blue Light Filter | Clear |
---|---|---|
Arm/Group Description | Blue light filter clip-on glasses worn over habitual correction | Clear clip-on glasses worn over habitual correction |
Measure Participants | 145 | 144 |
Mean (Standard Deviation) [seconds] |
5.66
(6.20)
|
6.94
(7.16)
|
Adverse Events
Time Frame | Adverse events (AEs) were collected for the duration of the study (30 Sep 2013 to 22 Jan 2014). This analysis group includes all enrolled participants. | |||
---|---|---|---|---|
Adverse Event Reporting Description | An AE was defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs in subjects, users or other persons, whether or not related to the investigational medical device. Reports of AEs were obtained through volunteered and elicited comments from the subjects. | |||
Arm/Group Title | Blue Light Filter | Clear | ||
Arm/Group Description | Blue light filter clip-on glasses worn over habitual correction | Clear clip-on glasses worn over habitual correction | ||
All Cause Mortality |
||||
Blue Light Filter | Clear | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
Blue Light Filter | Clear | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/158 (0%) | 0/158 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Blue Light Filter | Clear | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/158 (0%) | 0/158 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
Results Point of Contact
Name/Title | Melvin Sarayba, Franchise Head Cataract, GMA |
---|---|
Organization | Alcon Research, Ltd. |
Phone | 1-888-451-3937 |
alcon.medinfo@alcon.com |
- A01311